SCHEMBL312895

SCHEMBL312895

CC(C)(C)C(=O)Nc1ncc2cc[nH]c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 2/20 0.39
F2 P00734 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LRRK2 Q5S007 2/20 0.38
RIPK1 Q13546 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PIK3C3 Q8NEB9 1/20 0.36
PDGFRB P09619 2/20 0.36
SYK P43405 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19736365 0.83 PIK3C3 (0.47) ADORA1LRRK2RIPK1CYP1A2PIK3C3
SCHEMBL19728686 0.79 ADORA1 (0.42) ADORA1HSD17B10LRRK2RIPK1ALDH1A1
SCHEMBL3801893 0.75 ADORA1 (0.44) ADORA1L3MBTL1POLBMEN1KMT2A
SCHEMBL30009349 0.75 ABL1 (0.52) ADORA1LRRK2HPGDCDK8CDK7
SCHEMBL311465 0.74 MEN1 (0.47) ADORA1L3MBTL1POLBMEN1KMT2A
SCHEMBL14555749 0.73 AXL (0.39) L3MBTL1LRRK2RIPK1ALDH1A1SYK
SCHEMBL30219582 0.73 ULK1 (0.46) LRRK2RIPK1CDK8KDREGFR
SCHEMBL11916208 0.73 ULK1 (0.46) LRRK2RIPK1CDK8KDREGFR
SCHEMBL16266476 0.73 JAK2 (0.39) LRRK2PIK3C3CDK7CCNT1CDK9
SCHEMBL30406688 0.72 HRH4 (0.42) MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093229-B2 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2012-01-10 US disclosed
US-20090318387-A1 ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION 2009-12-24 US disclosed
US-7544672-B2 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2009-06-09 US disclosed
CN-101180297-A Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors CONFORMA THERAPEUTICS CORP (US) 2008-05-14 CN disclosed
EP-1869027-A2 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS Conforma Therapeutics Corporation (US) 2007-12-26 EP disclosed
US-20060223797-A1 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION 2006-10-05 US disclosed
WO-2006105372-A2 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318387-A1 ALKYNYL PYRROLO[2,3-d]PYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS HSP90AB2P, HSP90AB1, HSP90AA1 ADORA1 4290/4885L3MBTL1 1755/4885POLB 636/4885
US-20060223797-A1 ALKYNYL PYRROLOPYRIMIDINES AND RELATED ANALOGS AS HSP90-INHIBITORS HSP90AB2P, HSP90AB1, HSP90AA1 ADORA1 4689/4885L3MBTL1 1546/4885POLB 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.